NFE2L2 and hepatocellular carcinoma: Other studies have also supported the association between NRF2–ARE signaling and the PD‐L1 expression in various solid tumors, including non‐small cell lung carcinoma, hepatocellular carcinoma, colorectal carcinoma, and melanoma [49, 50, 51, 68].